Spring Fertility Company Profile

Background

Overview

Spring Fertility is a leading provider of fertility care services, established in 2016 and headquartered in San Francisco, California. The company offers a comprehensive range of reproductive health services, including in vitro fertilization (IVF), egg freezing, genetic counseling, and advanced reproductive surgeries. With a patient-centric approach, Spring Fertility aims to redefine the fertility care experience by combining scientific excellence with compassionate support.

Mission and Vision

Spring Fertility's mission is to empower individuals and couples to achieve their family-building goals through personalized and innovative fertility treatments. The company's vision is to set a new standard in fertility care by integrating advanced medical technologies with a supportive and individualized patient experience.

Industry Significance

Since its inception, Spring Fertility has rapidly become a prominent player in the fertility care sector, particularly in Northern California. The company's commitment to high-quality care and patient satisfaction has positioned it as a leading choice for those seeking reproductive health services.

Key Strategic Focus

Core Objectives

Patient-Centric Care: Develop personalized treatment plans tailored to each patient's unique needs and goals.

Scientific Innovation: Integrate cutting-edge medical technologies and research to enhance treatment outcomes.

Accessibility: Provide transparent pricing and flexible financial options to make fertility treatments more accessible.

Areas of Specialization

In Vitro Fertilization (IVF): Offer comprehensive IVF services with high success rates.

Egg Freezing: Provide egg preservation services for individuals planning to delay parenthood.

Genetic Counseling: Assist patients in understanding genetic factors affecting fertility and reproductive health.

Advanced Reproductive Surgery: Perform surgical procedures to address complex fertility issues.

Key Technologies Utilized

State-of-the-Art Laboratories: Utilize advanced lab technologies to maximize success rates in fertility treatments.

Customized Environmental Controls: Implement unique lab environments that replicate the body's internal conditions to improve embryo development.

Primary Markets Targeted

Spring Fertility primarily serves patients in Northern California, with plans to expand access to its care platform across North America. The company operates clinics in San Francisco, East Bay, Silicon Valley, and New York City.

Financials and Funding

Funding History

Spring Fertility has raised a total of $3 million across two funding rounds. The most recent funding round was a Series B in June 2019, led by Wildcat Capital Management.

Utilization of Capital

The capital raised has been utilized to fuel scientific innovation, expand access to fertility care services, and enhance the company's technological capabilities. This includes the development of state-of-the-art laboratories and the implementation of advanced reproductive technologies.

Pipeline Development

Key Pipeline Candidates

Spring Fertility focuses on developing and refining its fertility treatment protocols, including IVF and egg freezing procedures, to improve success rates and patient outcomes. The company is also involved in ongoing research to advance genetic counseling services and explore novel therapeutic options for fertility patients.

Anticipated Milestones

Expansion of Services: Opening additional clinics in key markets to increase accessibility to fertility care.

Technological Advancements: Implementing new lab technologies to further enhance treatment outcomes.

Research Initiatives: Publishing findings from ongoing studies to contribute to the broader field of reproductive medicine.

Technological Platform and Innovation

Proprietary Technologies

Customized Lab Environments: Spring Fertility has developed unique lab conditions that closely mimic the body's internal environment, leading to a significant reduction in embryo attrition rates.

Significant Scientific Methods

Advanced Laboratory Techniques: Employing cutting-edge laboratory procedures to improve embryo development and increase success rates in fertility treatments.

Genetic Testing: Utilizing comprehensive genetic screening to provide patients with detailed information about their reproductive health.

Leadership Team

Key Executives

Peter Klatsky, MD, MPH – Co-Founder & CEO: Dr. Klatsky co-founded Spring Fertility in 2016 and serves as the Chief Executive Officer. He is a fertility specialist with extensive experience in reproductive medicine.

Nam Tran, MD, PhD – Chief Medical Officer & Scientific Director: Dr. Tran is the Chief Medical Officer and Scientific Director at Spring Fertility. He has directed research at leading academic centers and is dedicated to translating scientific innovations into patient care.

Derald Sue – Chief Operating Officer and CIO: Mr. Sue serves as the Chief Operating Officer and Chief Information Officer at Spring Fertility, overseeing the company's operations and technological infrastructure.

Recent Leadership Changes

In August 2025, Mike Michetti joined Spring Fertility as the Chief Executive Officer, bringing extensive experience in healthcare management to the organization.

Competitor Profile

Market Insights and Dynamics

The fertility care market is experiencing significant growth, driven by increasing awareness of reproductive health and advancements in fertility treatments. Key trends include the adoption of personalized treatment plans, integration of advanced technologies, and a focus on patient-centered care.

Competitor Analysis

Prelude Fertility: A network of fertility clinics offering a range of reproductive health services.

CCRM IVF: A network of fertility clinics providing comprehensive fertility treatments.

IntegraMed Fertility: A provider of fertility services with a focus on patient care and treatment outcomes.

Strategic Collaborations and Partnerships

Spring Fertility has partnered with organizations like Headspace to offer mental health resources for individuals navigating fertility challenges.

Operational Insights

Spring Fertility differentiates itself through its patient-centric approach, advanced laboratory technologies, and commitment to scientific innovation, positioning it as a leader in the fertility care sector.

Strategic Opportunities and Future Directions

Strategic Roadmap

Expansion: Opening additional clinics in key markets to increase accessibility to fertility care services.

Technological Advancements: Continuing to invest in state-of-the-art laboratory technologies to enhance treatment outcomes.

Research and Development: Engaging in ongoing research to develop novel therapeutic options and contribute to the field of reproductive medicine.

Future Business Directions

Spring Fertility aims to expand its presence across North America, enhance its technological capabilities, and continue to provide personalized, high-quality fertility care to a diverse patient population.